Skip to content

Predictors of Acute and Persistent Postoperative Pain in Lung Cancer Surgery

Predictors of Acute and Persistent Postoperative Pain in Lung Cancer Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05599386
Enrollment
100
Registered
2022-10-31
Start date
2022-11-01
Completion date
2024-08-06
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The aim of this observational study is to investigate if preoperative quantitative sensory testing, anxiety and depression symptoms, and biological markers are associated with the risk of developing acute and chronic postoperative pain after video-assisted Thoracoscopic surgery (VATS).

Detailed description

This observational study examine acute and chronic postoperative pain in patients undergoing VATS. In the study preoperative biomarkers, quantitative sensory testing and questionnaires are used to create prediction models for acute and chronic postoperative pain. The study will serve as background information on the risk factors and predictive factors as well as an exploration of the impact of surgical stress from VATS on circulation microRNA and inflammatory mediators.

Interventions

DIAGNOSTIC_TESTPreoperative test

Patients are subject to quantitative sensory testing, questionnaires, and biomarker analysis prior to surgery.

Sponsors

Aalborg University
CollaboratorOTHER
Jannie Bisgaard Stæhr
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults independent of sex with an age of ≥ 18 years * Patients scheduled for VATS as a part of either examination or radical treatment of lung cancer

Exclusion criteria

* Patients who are unable to understand oral and written information. * Patients with known chronic pain in the thorax which have been persisting for at least six months before the day of surgery. * Pregnant and nursing women. * Patients receiving a planned preoperative epidural blockade during their stay. * Patients converted to open surgery.

Design outcomes

Primary

MeasureTime frameDescription
Numerical Rating Scale48 hours postoperativePain intensity on a Numerical Rating Scale ranging from 0 indicating no pain to 10 indicating worst pain imaginable during the first two postoperative days.

Secondary

MeasureTime frameDescription
Total equipotent opioid doseTotal equipotent opioid dose in milligrams during the first 48 hours after surgery.48 hours postoperative
Time to first administration of opioidTime in hours to first postoperative administration of Pro Re Nata (PRN) opioids48 hours postoperative
Mobilisation48 hours postoperativeTime in hours to full mobilisation defined as walking with or without aids.
Patient-reported satisfaction of postoperative pain management assessed by self-made questionnaire in DanishMeasured twice. Once 48 hours after surgery or at non fixed time(on average 4 days and a maximum of 3 months) as well as at 365 daysPatients are asked to fill out a questionnaire rating their general satisfaction with pain management and sufficiency of pain treatment on a scale from 0 to 10. The questionnaire also assess whether the patients had any perceived side effects and how uncomfortable they were on a scale from 0 to 10.

Other

MeasureTime frameDescription
Examination of the level of inflammatory biomarkers (IL-6, IL-8, TNFa, etc.) and circulation microRNA48 hours postoperativeChange in expression of microRNA and Inflammatory mediators from before surgery until two days after surgery

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026